Dr. Geoffrey Wayne Tobias, MO Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 214 Engle St, Englewood, NJ 07631 Phone: 201-567-6770 Fax: 201-567-7966 |
Lindsay Princer, PA-C Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Medicare Enrolled Practice Location: 23 W Palisade Ave, Englewood, NJ 07631 Phone: 516-712-7501 |
Dr. Bryan T Ho, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 216 Engle St, Ste 101, Englewood, NJ 07631 Phone: 201-816-9800 Fax: 201-567-1569 |
Dr. Kenneth Fred Garay, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 475 Grand Ave, Englewood, NJ 07631 Phone: 201-871-4545 Fax: 201-871-9658 |
Dr. Kevin Howard Ende, MD Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 23 West Palisade Ave, Englewood, NJ 07631 Phone: 201-408-4441 |
David Lewis, MD Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 216 Engle St Ste 101, Englewood, NJ 07631 Phone: 201-816-9800 |
News Archive
Neuroscientists from Wayne State University and the Massachusetts Institute of Technology (MIT) are taking a deeper look into how the brain mechanisms for memory retrieval differ between adults and children.
The Overactive Bladder Symptom Score questionnaire is valuable for assessing the impact of OAB symptoms on women's health-related quality of life, shows a large survey of Japanese women.
The Obama administration on Wednesday asked an appeals court for an emergency stay that would lift the ban on federal funding of research involving human embryonic stem cells. U.S. District Judge Royce Lamberth last month ruled that the research violated U.S. law because it involved destroying human embryos, a setback for President Barack Obama who had tried to expand research in hopes it would lead to new cures of diseases.
Relief of pain and stress for children receiving emergency medical treatment is a vital, and readily available, component of care.
Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it was awarded two grants totaling $488,959 under the Qualifying Therapeutic Discovery Project (QTDP) Program to support the Company's Alzheimer's disease and multiple sclerosis programs currently in clinical testing.
› Verified 4 days ago